CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
July 2017—Hemo Bioscience announced its MQC-CAT—a ready-to-use quality control product for manual column agglutination technology blood bank testing methods—has received FDA 510(k) clearance.
Validated for use in all manual CAT testing systems currently available in the U.S., MQC-CAT includes positive and negative red cells and serums to ensure that ABO and RhD as well as antibody screening and identification reagents are performing as expected.
Hemo Bioscience, 919-313-2888